Episodi
-
touchEXPERT OPINIONS for touchONCOLOGY
Three experts share insights into the unmet treatment needs for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, the rationale for developing additional immunotherapy-based strategies and targeted therapies, and the latest data and ongoing trials for these investigational approaches.
The experts
Dr Aline Chaves - DOM Oncology Group, Divinópolis, BrazilProf. Makoto Tahara - National Cancer Center Hospital East, Kashiwa, JapanDr Ranee Mehra - Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USAThis touchPODCAST is for healthcare professionals outside of the UK only.
This activity is funded by an independent medical educational grant from Seagen Inc. and Genmab US, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:https://touchoncologyime.org/future-treatment-of-recurrent-metastatic-scchn/
-
touchTALKS for touchONCOLOGY
Listen to a leading expert in lung cancer discuss the role of antibody–drug conjugates (ADCs) in the treatment of patients with advanced non-small cell lung cancer, including their structure and mechanistic rationale, the latest clinical trial data and the optimal management of patients receiving ADCs.
The expert
Dr Rebecca Heist – Massachusetts General Hospital, Boston, MA, USAThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca and is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
-
Episodi mancanti?
-
touchFOCUS for touchIMMUNOLOGY
Listen to Dr Antonella Cianferoni as she answers a series of questions on the diagnosis and management of food allergies.
The expert
Dr Antonella Cianferoni - Children’s Hospital of Philadelphia, PA, USAThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Thermo Fisher Scientific. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/expert-insights-in-food-allergy-considerations-for-diagnosis-and-management-in-primary-care-and-beyond/
-
touchFOCUS for touchRESPIRATORY
Listen to Dr Antonella Cianferoni as she answers a series of questions on the diagnosis and management of food allergies.
The expert
Dr Antonella Cianferoni - Children’s Hospital of Philadelphia, PA, USAThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Thermo Fisher Scientific. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/expert-insights-in-food-allergy-considerations-for-diagnosis-and-management-in-primary-care-and-beyond/
-
touchTALKS for touchRESPIRATORY
Listen to a leading expert in lung cancer discuss the role of antibody–drug conjugates (ADCs) in the treatment of patients with advanced non-small cell lung cancer, including their structure and mechanistic rationale, the latest clinical trial data and the optimal management of patients receiving ADCs.
The expert
Dr Rebecca Heist – Massachusetts General Hospital, Boston, MA, USAThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca and is jointly provided by USF Health and touchIME.
For further information visit our website: touchrespiratory.com
-
touchFOCUS for touchRESPIRATORY
Dr Ann-Marie Schoos answers a series of questions on the diagnosis and management of pet allergies, including the role of component-resolved diagnostics in providing a detailed analysis of patients' sensitization profiles to allow for a more personalized approach to management.
The expert:
Dr Ann-Marie Schoos - University of Copenhagen, DenmarkThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Thermo Fisher Scientific. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchimmunology.com
-
touchFOCUS for touchIMMUNOLOGY
Dr Ann-Marie Schoos answers a series of questions on the diagnosis and management of pet allergies, including the role of component-resolved diagnostics in providing a detailed analysis of patients' sensitization profiles to allow for a more personalized approach to management.
The expert:
Dr Ann-Marie Schoos - University of Copenhagen, DenmarkThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Thermo Fisher Scientific. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchimmunology.com
-
touchEXPERT OPINIONS for touchHAEMATOLOGY
Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents.
The experts
Prof. Cristina Gasparetto - Duke Cancer Institute, Durham, NC, USAProf. Sagar Lonial - Emory University, Atlanta, GA, USAProf. Sundar Jagannath - Tisch Cancer Institute, New York, NY, USAThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchhaematologyime.org/eo-in-rrmm
-
touchEXPERT OPINIONS for touchONCOLOGY
Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents.
The experts
Prof. Cristina Gasparetto - Duke Cancer Institute, Durham, NC, USAProf. Sagar Lonial - Emory University, Atlanta, GA, USAProf. Sundar Jagannath - Tisch Cancer Institute, New York, NY, USAThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/eo-in-rrmm
-
touchEXPERT OPINIONS for touchIMMUNOLOGY
Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care.
The experts:
Dr Efrem Eren, Southampton General Hospital, UKDr Nirmala Gonsalves, Northwestern University Feinberg School of Medicine, Chicago, USADr Jamal Hayat, St George's University Hospitals NHS Trust, London, UKThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME.
For further information visit: https://touchimmunology.org/eoe-diagnosis-treatment
-
touchEXPERT OPINIONS for touchRESPIRATORY
Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care.
The experts:
Dr Efrem Eren, Southampton General Hospital, UKDr Nirmala Gonsalves, Northwestern University Feinberg School of Medicine, Chicago, USADr Jamal Hayat, St George's University Hospitals NHS Trust, London, UKThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME.
For further information visit: https://touchrespiratoryime.org/eoe-diagnosis-treatment
-
touchMDT for touchIMMUNOLOGY
Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis.
The multidisciplinary team
Dermatologist: Prof. Martin Mertz, Berlin, GermanyDermatologist: Dr Manuel Pereira, Berlin, GermanyPsychodermatologist: Prof. Anthony Bewley, London, UKPatient advocate: Ms Sailaja Maganti, London, UKThis touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/
-
touchMDT for touchIMMUNOLOGY
Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis.
The multidisciplinary team
Dermatologist: Prof. Martin Mertz, Berlin, GermanyDermatologist: Dr Manuel Pereira, Berlin, GermanyPsychodermatologist: Prof. Anthony Bewley, London, UKThis touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/
-
touchMDT for touchIMMUNOLOGY
Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis.
The multidisciplinary team
Dermatologist: Prof. Martin Mertz, Berlin, GermanyDermatologist: Dr Manuel Pereira, Berlin, GermanyPsychodermatologist: Prof. Anthony Bewley, London, UKPatient advocate: Ms Sailaja Maganti, London, UKThis touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/
-
touchMDT for touchDERMATOLOGY
Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis.
The multidisciplinary team
Dermatologist: Prof. Martin Mertz, Berlin, GermanyDermatologist: Dr Manuel Pereira, Berlin, GermanyPsychodermatologist: Prof. Anthony Bewley, London, UKPatient advocate: Ms Sailaja Maganti, London, UKThis touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:https://touchdermaime.org/mdt-patient-centric-care-prurigo-nodularis//
-
touchMDT for touchDERMATOLOGY
Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis.
The multidisciplinary team
Dermatologist: Prof. Martin Mertz, Berlin, GermanyDermatologist: Dr Manuel Pereira, Berlin, GermanyPsychodermatologist: Prof. Anthony Bewley, London, UKThis touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:https://touchdermaime.org/mdt-patient-centric-care-prurigo-nodularis//
-
touchMDT for touchDERMATOLOGY
Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis.
The multidisciplinary team
Dermatologist: Prof. Martin Mertz, Berlin, GermanyDermatologist: Dr Manuel Pereira, Berlin, GermanyPsychodermatologist: Prof. Anthony Bewley, London, UKPatient advocate: Ms Sailaja Maganti, London, UKThis touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchdermaime.org/mdt-patient-centric-care-prurigo-nodularis//
-
touchFOCUS for touchONCOLOGY
A genitourinary medical oncologist considers the potential for targeting HER2 in the treatment of urothelial carcinoma, including the rationale for HER2 as a target, approaches to HER2 testing, the latest data on emerging HER2-targeted therapies and the potential implications for future clinical practice.
The expert:
Dr Vadim Koshkin - University of California San Francisco, CA, USAThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
-
touchIN CONVERSATION for touchIMMUNOLOGY
Listen to Dr Shounak Majumder (Mayo Clinic, Rochester, MN, USA) in conversation with Professor Matthias Löhr (Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden) on how to optimize the diagnosis and management of patients with IgG4-related gastrointestinal (GI) disease.
They respond to questions from the gastroenterology, hepatology and rheumatology clinical communities on:
Challenges of diagnosing IgG4-related GI diseaseDifferentiating type 1 autoimmune pancreatitis from type 2Therapeutic strategies for IgG4-related GI diseaseThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchimmunology.com
-
touchIN CONVERSATION for touchONCOLOGY
Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients with relapsed or refractory mantle cell lymphoma.
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
- Mostra di più